STOCK TITAN

Paragon 28 to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Paragon 28, Inc. (NYSE: FNA) announced that its Chairman and CEO, Albert DaCosta, and CFO, Steve Deitsch, will be presenting at two upcoming investor conferences. They will participate in the Stephens Annual Investment Conference on November 15, 2023, and the 35th Annual Piper Sandler Healthcare Conference on November 28, 2023. The fireside chats will be available for live and archived webcasts on the company's website at ir.paragon28.com.
Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will be presenting in fireside chats at two upcoming investor conferences. Paragon 28 will participate in the Stephens Annual Investment Conference on November 15, 2023, and the 35th Annual Piper Sandler Healthcare Conference on November 28, 2023.

Event: Stephens Annual Investment Conference
Date: Wednesday, November 15, 2023
Time: 5:00pm ET / 3:00pm MT

Event: 35th Annual Piper Sandler Healthcare Conference
Date: Tuesday, November 28, 2023
Time: 4:30pm ET / 2:30pm MT

Live and archived webcasts of the fireside chats will be available on the “Investors” section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact

Matthew Brinckman

Senior Vice President, Strategy and Investor Relations

Phone: (741) 336-0435

mbrinckman@paragon28.com

Source: Paragon 28, Inc.

FAQ

When and where will Paragon 28 be presenting at investor conferences?

Paragon 28 will be presenting at the Stephens Annual Investment Conference on November 15, 2023, and the 35th Annual Piper Sandler Healthcare Conference on November 28, 2023.

Who will be presenting on behalf of Paragon 28 at the investor conferences?

Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be presenting on behalf of Paragon 28.

Where can I watch the fireside chats?

The fireside chats will be available for live and archived webcasts on the 'Investors' section of Paragon 28's website at ir.paragon28.com.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

831.64M
49.79M
40.56%
61.27%
8.11%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD